Oligonucleotides as therapeutic agents - PubMed (original) (raw)

Review

Oligonucleotides as therapeutic agents

J S Cohen. Pharmacol Ther. 1991 Nov.

Abstract

Oligodeoxynucleotides can act as antisense complements to target sequences of mRNAs to selectively regulate gene expression. Chemically modified analogs that are nuclease-resistant enable this antisense strategy to be utilized in practice. Studies with oligodeoxynucleotide analogs in cell free systems, and their cellular uptake will be described. Certain analogs have been found to regulate viral and cellular gene expression. However, some also inhibit in a non-specific manner, that may be traced to their selective inhibition of viral and cellular polymerases. A chemically modified oligodeoxynucleotide analog can be regarded as an informational drug.

PubMed Disclaimer

Similar articles

• Selective anti-gene therapy for cancer: principles and prospects.
  Cohen JS. Cohen JS. Tohoku J Exp Med. 1992 Oct;168(2):351-9. doi: 10.1620/tjem.168.351. Tohoku J Exp Med. 1992. PMID: 1306320 Review.
• Application of antisense technology to therapeutics.
  Heidenreich O, Kang SH, Xu X, Nerenberg M. Heidenreich O, et al. Mol Med Today. 1995 Jun;1(3):128-33. doi: 10.1016/s1357-4310(95)80090-5. Mol Med Today. 1995. PMID: 9415148 Review.
• Control of gene expression by oligonucleotides covalently linked to intercalating agents.
  Hélène C, Thuong NT. Hélène C, et al. Genome. 1989;31(1):413-21. doi: 10.1139/g89-062. Genome. 1989. PMID: 2687107 Review.
• The therapeutic potential of antisense oligonucleotides.
  Sharma HW, Narayanan R. Sharma HW, et al. Bioessays. 1995 Dec;17(12):1055-63. doi: 10.1002/bies.950171210. Bioessays. 1995. PMID: 8634067 Review.
• Oligodeoxynucleotide analogs as informational drugs to regulate translation.
  Ghosh M, Ghosh K, Cohen JS. Ghosh M, et al. Nucleic Acids Symp Ser. 1991;(24):139-42. Nucleic Acids Symp Ser. 1991. PMID: 1668685

Cited by

• Hepatic distribution and clearance of antisense oligonucleotides in the isolated perfused rat liver.
  Nolting A, DeLong RK, Fisher MH, Wickstrom E, Pollack GM, Juliano RL, Brouwer KL. Nolting A, et al. Pharm Res. 1997 Apr;14(4):516-21. doi: 10.1023/a:1012116003706. Pharm Res. 1997. PMID: 9144742
• Investigation of some properties of oligodeoxynucleotides containing 4'-thio-2'-deoxynucleotides: duplex hybridization and nuclease sensitivity.
  Jones GD, Lesnik EA, Owens SR, Risen LM, Walker RT. Jones GD, et al. Nucleic Acids Res. 1996 Nov 1;24(21):4117-22. doi: 10.1093/nar/24.21.4117. Nucleic Acids Res. 1996. PMID: 8932360 Free PMC article.
• Designing highly active siRNAs for therapeutic applications.
  Walton SP, Wu M, Gredell JA, Chan C. Walton SP, et al. FEBS J. 2010 Dec;277(23):4806-13. doi: 10.1111/j.1742-4658.2010.07903.x. FEBS J. 2010. PMID: 21078115 Free PMC article. Review.
• Synthesis and hybridization properties of oligonucleotides containing 2'-O-modified ribonucleotides.
  Keller TH, Häner R. Keller TH, et al. Nucleic Acids Res. 1993 Sep 25;21(19):4499-505. doi: 10.1093/nar/21.19.4499. Nucleic Acids Res. 1993. PMID: 8233783 Free PMC article.
• Sequence-specific interaction of alpha-beta-anomeric double-stranded DNA with the p50 subunit of NF kappa B: application to the decoy approach.
  Tanaka H, Vickart P, Bertrand JR, Rayner B, Morvan F, Imbach JL, Paulin D, Malvy C. Tanaka H, et al. Nucleic Acids Res. 1994 Aug 11;22(15):3069-74. doi: 10.1093/nar/22.15.3069. Nucleic Acids Res. 1994. PMID: 8065920 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database